These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9850350

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Haas HG.
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The microscopic morphology of fluoride-induced bone.
    Vigorita VJ, Suda MK.
    Clin Orthop Relat Res; 1983 Jun; (177):274-82. PubMed ID: 6407795
    [Abstract] [Full Text] [Related]

  • 25. Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus.
    Weinstein RS, Underwood JL, Hutson MS, DeLuca HF.
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E499-505. PubMed ID: 6377910
    [Abstract] [Full Text] [Related]

  • 26. Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.
    Zerwekh JE, Antich PP, Sakhaee K, Prior J, Gonzales J, Gottschalk F, Pak CY.
    Bone Miner; 1992 Jul; 18(1):65-76. PubMed ID: 1422299
    [Abstract] [Full Text] [Related]

  • 27. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?
    Lems WF, Jacobs JW, Bijlsma JW, van Veen GJ, Houben HH, Haanen HC, Gerrits MI, van Rijn HJ.
    Ann Rheum Dis; 1997 Jun; 56(6):357-63. PubMed ID: 9227164
    [Abstract] [Full Text] [Related]

  • 28. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
    Chavassieux PM, Arlot ME, Roux JP, Portero N, Daifotis A, Yates AJ, Hamdy NA, Malice MP, Freedholm D, Meunier PJ.
    J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
    [Abstract] [Full Text] [Related]

  • 29. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
    Nagant de Deuxchaisnes C, Devogelaer JP, Depresseux G, Malghem J, Maldague B.
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies?
    Gutteridge DH, Kent GN, Prince RL, Nicholson GC, Stewart GO, Jones CE, Bhagat CI, Stuckey BG, Retallack RW.
    Osteoporos Int; 1993 Mar; 3 Suppl 1():215-7. PubMed ID: 8461565
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anabolic effects of fluoride on bone.
    Pak CY, Zerwekh JE, Antich P.
    Trends Endocrinol Metab; 1995 Sep; 6(7):229-34. PubMed ID: 11540313
    [Abstract] [Full Text] [Related]

  • 35. The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology.
    Lundy MW, Wergedal JE, Teubner E, Burnell J, Sherrard D, Baylink DJ.
    Bone; 1989 Sep; 10(5):321-7. PubMed ID: 2605048
    [Abstract] [Full Text] [Related]

  • 36. Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride.
    Boivin G, Duriez J, Chapuy MC, Flautre B, Hardouin P, Meunier PJ.
    Osteoporos Int; 1993 Jul; 3(4):204-8. PubMed ID: 8338976
    [Abstract] [Full Text] [Related]

  • 37. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
    Fratzl P, Roschger P, Eschberger J, Abendroth B, Klaushofer K.
    J Bone Miner Res; 1994 Oct; 9(10):1541-9. PubMed ID: 7817799
    [Abstract] [Full Text] [Related]

  • 38. [Value of bone fluoride determination in osteoporotic patients treated with sodium fluoride].
    Laurent V, de Vernejoul MC, Brouard A, Terrier JL, Miravet L, Kuntz D.
    Presse Med; 1989 Apr 01; 18(13):679-82. PubMed ID: 2524040
    [Abstract] [Full Text] [Related]

  • 39. Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis.
    Bravenboer N, Papapoulos SE, Holzmann P, Hamdy NA, Netelenbos JC, Lips P.
    Osteoporos Int; 1999 Apr 01; 9(6):489-93. PubMed ID: 10624455
    [Abstract] [Full Text] [Related]

  • 40. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J.
    Bone; 2009 Jan 01; 44(1):113-9. PubMed ID: 18983947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.